{"id":791,"date":"2026-09-01T17:35:05","date_gmt":"2026-09-01T17:35:05","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"},"modified":"2026-09-08T07:30:41","modified_gmt":"2026-09-08T07:30:41","slug":"melanotan-ii-human-pilot-toxicity-regulatory-evidence","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/es\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","title":{"rendered":"Melanotan II: datos de pilotos humanos, toxicidad y estado regulatorio"},"content":{"rendered":"
Melanotan II tiene datos limitados sobre exposici\u00f3n humana temprana y da\u00f1os documentados por el uso no regulado. Un piloto de bronceado de tres personas no puede compensar los informes de toxicidad posteriores o las advertencias actuales de los reguladores.<\/p>
Evidencia de un vistazo<\/h2>
El piloto simple ciego de 1996 inscribi\u00f3 a tres voluntarios varones sanos y utiliz\u00f3 d\u00edas alternos de soluci\u00f3n salina o Melanotan II.<\/li>
Con 0.03 mg\/kg, uno de dos participantes ten\u00eda somnolencia y fatiga de grado II; Tambi\u00e9n se informaron n\u00e1useas y erecciones espont\u00e1neas prolongadas.<\/li>
Una exposici\u00f3n confirmada a mg de 6 en un hombre de 39 a\u00f1os fue seguida de taquicardia, disfunci\u00f3n renal y aumento de CPK de 1,760 a 17,773 IU\/L.<\/li><\/ul><\/div><\/div>Ilustraci\u00f3n editorial generada por AI que ilustra el flujo de trabajo de la investigaci\u00f3n. No es una figura de estudio, una imagen de un paciente, una fotograf\u00eda de un producto, un resultado de un ensayo ni un lote de cat\u00e1logo.<\/figcaption><\/figure>
Registro de estudio<\/h2>
La fase piloto I fue dise\u00f1ada para observar efectos a corto plazo, no para establecer la seguridad de la poblaci\u00f3n. Tres participantes son insuficientes para estimar los eventos adversos poco comunes y el resultado no valida los productos de Internet actuales.<\/p>
Se\u00f1ales piloto<\/strong>Pigmentaci\u00f3n en 2; Se informaron n\u00e1useas, somnolencia\/fatiga y erecciones.<\/span><\/div>
caso 2012<\/strong>Hombre de 39 a\u00f1os; 6 mg material comprado por Internet confirmado por espectrometr\u00eda de masas<\/span><\/div>
Pico CPK<\/strong>17,773 IU\/L a las horas de 12<\/span><\/div>
L\u00edmite regulatorio<\/strong>FDA describe a Melanotan II como un nuevo f\u00e1rmaco no aprobado; TGA encontr\u00f3 contenido de productos en l\u00ednea inconsistente<\/span><\/div><\/div><\/div>
Resultados en contexto<\/h2>
En el caso de toxicolog\u00eda de 2012, la frecuencia card\u00edaca alcanz\u00f3 146 latidos por minuto, la creatinina fue de 2.25 mg\/dL, CPK luego alcanz\u00f3 su punto m\u00e1ximo en 17,773 IU\/L y el tratamiento de cuidados intensivos dur\u00f3 tres d\u00edas. La espectrometr\u00eda de masas confirm\u00f3 Melanotan II frente a un est\u00e1ndar, fortaleciendo la atribuci\u00f3n de exposici\u00f3n sin dejar de ser un caso \u00fanico.<\/p>
En agosto, 2026, el TGA de Australia inform\u00f3 que cinco frascos de aerosol nasal incautados con la etiqueta 30 mg conten\u00edan cantidades estimadas que oscilaban entre 22 y 54 mg. Esta inconsistencia en el mundo real es un riesgo de dosificaci\u00f3n y calidad del producto independiente de la farmacolog\u00eda de la mol\u00e9cula.<\/p>
Lo que la evidencia no puede establecer<\/h2>
La muestra piloto de tres no puede establecer seguridad o eficacia.<\/p>
Un informe de caso no puede estimar la incidencia, pero puede documentar un evento grave plausible.<\/p>
El contenido de un producto no regulado no se puede deducir de una etiqueta y los materiales de investigaci\u00f3n del cat\u00e1logo no son medicamentos aprobados.<\/p>","protected":false},"excerpt":{"rendered":"
Melanotan II tiene datos limitados sobre exposici\u00f3n humana temprana y da\u00f1os documentados por el uso no regulado. Un piloto de bronceado de tres personas no puede compensar los informes de toxicidad posteriores o las advertencias actuales de los reguladores.<\/p>","protected":false},"author":1,"featured_media":775,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"350","pim_article_type":"Published evidence review","pim_evidence_level":"Three-person phase I pilot, case reports and current regulatory safety warnings","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, sample size, model\/population limits and regulatory scope are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary and official sources, numerical results, null findings, limitations, product-evidence boundary and image disclosure checked for batch 4.","pim_creation_method":"This article discusses the source records listed below, with the study models and limitations stated alongside the findings. AI-assisted drafting and image generation were used. The reference list identifies the records behind this article; it is not an independent peer review or verification of a supplied catalog lot.","pim_sources":"[{\"title\":\"Melanotan II pilot phase I study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/8637402\/\",\"note\":\"Three-person single-blind pilot; PMID 8637402.\"},{\"title\":\"Melanotan II systemic toxicity and rhabdomyolysis\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23121206\/\",\"note\":\"Mass-spectrometry-confirmed case report; PMID 23121206.\"},{\"title\":\"TGA finds inconsistent Melanotan II content\",\"url\":\"https:\/\/www.tga.gov.au\/safety\/safety-monitoring-and-information\/safety-alerts\/melanotan-ii-tanning-peptide-products-found-be-inconsistently-dosed\",\"note\":\"Official August 2026 laboratory-testing safety alert.\"},{\"title\":\"FDA Melanotan II enforcement record\",\"url\":\"https:\/\/www.fda.gov\/regulatory-information\/electronic-reading-room\/notice-opportunity-hearing-nooh-manookian-edward-8516\",\"note\":\"Official record describing Melanotan II as an unapproved new drug.\"},{\"title\":\"PubChem Melanotan II record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/melanotan-II\",\"note\":\"Cyclic sequence, formula and molecular weight; CID 92432.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-791","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"\n
Melanotan II: Human Pilot Data, Toxicity and Regulatory Status<\/title>\n<meta name=\"description\" content=\"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/es\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\" \/>\n<meta property=\"og:description\" content=\"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/es\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T17:35:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T07:30:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\"},\"wordCount\":334,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\",\"name\":\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"description\":\"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"width\":1672,\"height\":941,\"caption\":\"AI-generated illustration: clinical-toxicology case review\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/es\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Melanotan II: datos de pilotos humanos, toxicidad y estado regulatorio","description":"Melanotan II tiene datos limitados sobre exposici\u00f3n humana temprana y da\u00f1os documentados por el uso no regulado. Un piloto de bronceado de tres personas no puede compensar la toxicidad posterior...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/es\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","og_locale":"es_ES","og_type":"article","og_title":"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status","og_description":"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026","og_url":"https:\/\/nhdbio.com\/es\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","og_site_name":"NHD","article_published_time":"2026-09-01T17:35:05+00:00","article_modified_time":"2026-09-08T07:30:41+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"},"wordCount":334,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","articleSection":["Published Study Reviews"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","url":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","name":"Melanotan II: datos de pilotos humanos, toxicidad y estado regulatorio","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","description":"Melanotan II tiene datos limitados sobre exposici\u00f3n humana temprana y da\u00f1os documentados por el uso no regulado. Un piloto de bronceado de tres personas no puede compensar la toxicidad posterior...","breadcrumb":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","width":1672,"height":941,"caption":"AI-generated illustration: clinical-toxicology case review"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Materias primas pept\u00eddicas y s\u00edntesis personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipo t\u00e9cnico de NHD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"El equipo t\u00e9cnico de NHD mantiene documentaci\u00f3n del cat\u00e1logo de uso de investigaci\u00f3n y res\u00famenes de evidencia. Los art\u00edculos revisados \u200b\u200benlazan con art\u00edculos revisados \u200b\u200bpor pares, registros de ensayos y registros regulatorios, conservan hallazgos nulos y limitaciones de estudios, y distinguen las intervenciones publicadas de los materiales del cat\u00e1logo. Se puede utilizar dibujo asistido por AI para la estructura; los enlaces de fuentes y los l\u00edmites de las pruebas permanecen visibles. Este trabajo no es una revisi\u00f3n por pares independiente ni un consejo m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/es\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/comments?post=791"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/791\/revisions"}],"predecessor-version":[{"id":1196,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/791\/revisions\/1196"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media\/775"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media?parent=791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/categories?post=791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/tags?post=791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Revisi\u00f3n](\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp\")